Demographic Data |
Relation to Proband |
proband |
Age at Sampling |
2 YR |
Sex |
Male |
Age at Diagnosis(If not a control) |
4 MO |
Hispanic or Latino/Not Hispanic or Latino |
Not Hispanic/Latino |
Racial Category |
White |
Country |
USA |
|
Data Elements |
Clinical Element Type: General NIGMS Catalog Remarks |
(Baseline) |
Mutation Information |
Gene, variant, consequence, and exon number: |
CLDN11, C.515DEL (P.G172FS), FRAMESHIFT (DE NOVO), EXON 3 |
Zygosity: |
Heterozygous |
Other variants: |
MT-ATP6, M.8720G>A (P.G65E), VUS, ~40% HETEROPLASMY |
Age of Symptom Onset and Age at Diagnosis |
Age of Symptom Onset: |
AT BIRTH |
Age at Diagnosis: |
4 MONTHS |
In Utero History Information |
|
|
Birth History Information |
|
Failure to thrive
|
Dysmorphic Features |
|
|
Additional Information: |
MICROGNATHIA |
Neurological Symptoms |
|
Hypertonia Hypotonia
|
Additional Information: |
DYSAUTONOMIA |
Optical and Audiological Symptoms |
|
|
Musculoskeletal Symptoms |
|
|
Additional Information: |
RETROGNATHIA |
Developmental Milestones |
|
Delayed speech and language development Global developmental delay Delayed fine motor skills Delayed gross motor skills
|
Gastrointestinal Symptoms |
|
Eating difficulties
|
Additional Information: |
DYSPHAGIA |
Genitourinary Symptoms |
|
|
Respiratory and Cardiovascular Symptoms |
|
|
Additional Information: |
AERODIGESTIVE DISORDERS: LUNG
LARYNGOMALACIA |
Cognitive and Behavioral Symptoms |
|
|
Additional Information: |
NEUROIRRITABILITY |
Additional Information |
Testing Performed |
Treatments and Assistive Devices |
|
Occupational therapy Physical therapy Speech therapy Wheelchair or ambulation devices Orthotics Communication or learning devices
|
Surgeries |
G-TUBE PLACEMENT
SUPRAGLOTTOPLASTY |
Additional Testing: |
BRACES
IMMOBILIZER |
Medications |
|
BOTOX (PYLORUS, ARMS, HANDS)
GABAPENTIN
CYPROHEPTADINE
FLOVENT
LANSOPRAZOLE
LORAZEPAM
CLONIDINE
ONDANSETRON
ALBUTEROL
OXYGEN
TRIAMCINOLONE |
Family History |
Remarks |
Clinically affected. See "Phenotypic Data Tab" |